tiprankstipranks
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
US Market
EYPT
EyePoint Pharmaceuticals
RESEARCH TOOLSreports

EyePoint Pharmaceuticals (EYPT) Stock News & Sentiment

1,001 Followers
EyePoint Sues Ocular Therapeutix Over Alleged Defamation
Premium
Company Announcements
EyePoint Sues Ocular Therapeutix Over Alleged Defamation
22d ago
8K
EYPT
EyePoint’s COMO Phase 3 Trial Puts Long-Acting DME Strategy in Focus
Premium
Company Announcements
EyePoint’s COMO Phase 3 Trial Puts Long-Acting DME Strategy in Focus
26d ago
EYPT
EyePoint Pharmaceuticals: Strong Clinical Momentum, Favorable Risk‑Reward, and Catalyst‑Rich Path to Duravyu Approval Support Buy Rating
Premium
Ratings
EyePoint Pharmaceuticals: Strong Clinical Momentum, Favorable Risk‑Reward, and Catalyst‑Rich Path to Duravyu Approval Support Buy Rating
1M ago
EYPT
EyePoint Pharma Bets Big on DuraVu in Pivotal Push
Premium
Company Announcements
EyePoint Pharma Bets Big on DuraVu in Pivotal Push
1M ago
EYPT
EyePoint Starts Global Phase 3 Trials for DURAVYU
Premium
Company Announcements
EyePoint Starts Global Phase 3 Trials for DURAVYU
1M ago
8K
EYPT
Is EYPT a Buy, Before Earnings?
Premium
Pre-Earnings
Is EYPT a Buy, Before Earnings?
1M ago
EYPT
EyePoint Pharmaceuticals: Advancing DURAVYU Phase 3 Programs with Strong Cash Runway Supports Buy Rating and $23 Target
Premium
Ratings
EyePoint Pharmaceuticals: Advancing DURAVYU Phase 3 Programs with Strong Cash Runway Supports Buy Rating and $23 Target
3M ago
EYPT
More EYPT News >

EYPT News on the Web

Arvinas (ARVN) Moves 6.9% Higher: Will This Strength Last?
Zacks
Bearish
EyePoint Inc at RBC Capital Markets Ophthalmology Conference (Virtual) Transcript
GuruFocus News
Neutral
EyePoint (EYPT) Sues Ocular Therapeutix (OCUL) Over False Claims
GuruFocus News
Neutral
EyePoint Sues Ocular Therapeutix Over Alleged Defamation
TipRanks News
Neutral
Top Executive Makes Bold Insider Move at EyePoint Pharmaceuticals
TipRanks News
Neutral
EyePoint’s COMO Phase 3 Trial Puts Long-Acting DME Strategy in Focus
TipRanks News
Bullish
EyePoint reports inducement grants under NASDAQ listing rule
TipRanks News
Neutral
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment
The Motley Fool
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EYPT’s Media Buzz Sentiment?
Currently, no data Available
What is EYPT’s weekly average amount of articles?
Currently, no data Available
What is EYPT’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week